|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
17
|
|
pubmed:dateCreated |
2005-5-4
|
|
pubmed:abstractText |
Bare-metal stenting with abciximab pretreatment is currently considered a reasonable reperfusion strategy for acute ST-segment elevation myocardial infarction (STEMI). Sirolimus-eluting stents significantly reduce the need for target-vessel revascularization (TVR) vs bare-metal stents but substantially increase procedural costs. At current European list prices, the use of tirofiban instead of abciximab would absorb the difference in cost between stenting with sirolimus-eluting vs bare-metal stents.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1538-3598
|
|
pubmed:author |
pubmed-author:AnsaniLuciaL,
pubmed-author:BarbieriDarioD,
pubmed-author:BettiniAlessandroA,
pubmed-author:BoersmaEricE,
pubmed-author:CampoGianlucaG,
pubmed-author:CicchitelliGiordanoG,
pubmed-author:FerrariFabrizioF,
pubmed-author:FerrariRobertoR,
pubmed-author:GuardigliGabrieleG,
pubmed-author:MalaguttiPatriziaP,
pubmed-author:McFaddenEugène PEP,
pubmed-author:MerliniFabiaF,
pubmed-author:ParrinelloGiovanniG,
pubmed-author:PercocoGianfrancoG,
pubmed-author:STRATEGY Investigators,
pubmed-author:ValgimigliMarcoM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
4
|
|
pubmed:volume |
293
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2109-17
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15870414-Aged,
pubmed-meshheading:15870414-Angioplasty, Balloon, Coronary,
pubmed-meshheading:15870414-Antibodies, Monoclonal,
pubmed-meshheading:15870414-Drug Delivery Systems,
pubmed-meshheading:15870414-Female,
pubmed-meshheading:15870414-Humans,
pubmed-meshheading:15870414-Immunoglobulin Fab Fragments,
pubmed-meshheading:15870414-Immunosuppressive Agents,
pubmed-meshheading:15870414-Male,
pubmed-meshheading:15870414-Middle Aged,
pubmed-meshheading:15870414-Myocardial Infarction,
pubmed-meshheading:15870414-Platelet Aggregation Inhibitors,
pubmed-meshheading:15870414-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:15870414-Single-Blind Method,
pubmed-meshheading:15870414-Sirolimus,
pubmed-meshheading:15870414-Stents,
pubmed-meshheading:15870414-Tyrosine
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial.
|
|
pubmed:affiliation |
Chair of Cardiology, University of Ferrara, Cardiovascular Institute, Arcispedale S. Anna, Italy. vlgmrc@unife.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
